MyFinsight
Home
Blog
About
Contact
Download
Download image
something is missing
$3,963K
Net proceeds from
the loan
$623K
Net cash provided by
financing activities
$710K
Canceled cashflow
$3,876K
Net decrease in cash
and cash...
-$693K
Canceled cashflow
$710K
Common stock-based
compensation and expenses,...
$1,009K
Accounts payable
$241K
Depreciation and
amortization
$58K
Other items
$20K
Claims and advances
-$10K
Operating lease asset
-$2K
Net proceeds from
the issuance of...
-$3,876K
Net cash used in
operating activities
-$1,223K
Canceled cashflow
$1,340K
Net cash used in
investing activities
-$170K
Effects of exchange rate
changes on cash and cash...
-$10K
Net loss
-$2,402K
Accrued and other
liabilities
-$98K
Deposits and advances
$37K
Accounts receivable, net
$24K
Operating lease liability
-$2K
Acquisition and development
of intangible...
$169K
Purchase of property,
plant, and equipment
$1K
Back
Back
Cash Flow
IGC Pharma, Inc. (IGC)
IGC Pharma, Inc. (IGC)
source: myfinsight.com